Arm 1： Standard Synchronous Group
KY2025-309
Phase 2 small_molecule active
Quick answer
Arm 1： Standard Synchronous Group for Advanced Non-Small Cell Lung Cancer (NSCLC) is a Phase 2 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Advanced Non-Small Cell Lung Cancer (NSCLC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active